Waters Medical Systems
Waters Medical Systems empowers transplant teams to improve transplant success and graft survival rates through advanced organ preservation technologies. They focus on hypothermic oxygenated machine perfusion, static preservation, and innovative solutions like the RM4 platform and FDA-cleared DCX cassette, aiming to expand the donor pool, enhance organ viability, and support clinical research and transplantation outcomes.
Industries
Nr. of Employees
small (1-50)
Waters Medical Systems
2900 37th Street Northwest, building 003, Rochester, MN 55901
Products
Hypothermic oxygenated kidney perfusion system
Ex vivo perfusion platform combining pulsatile hypothermic perfusion and active oxygenation designed to preserve donor kidneys and extend preservation time.
Organ perfusion cassette with integrated oxygenation and hermetic sealing
Disposable or single-use cassette designed to house organ(s) during machine perfusion with direct oxygenation, full organ immersion, and hermetic lid to reduce contamination risk; supports one or two kidneys.
Pulsatile perfusion preservation solution
Formulated perfusion fluid optimized for use with machine perfusion systems to support organ metabolism and reduce ischemic injury during hypothermic pulsatile perfusion.
Cold storage preservation solutions (kidney, liver, pancreas, heart)
Preservation fluids for static cold storage of donor organs including formulations intended for kidney, liver, pancreas and heart preservation.
Hypothermic oxygenated kidney perfusion system
Ex vivo perfusion platform combining pulsatile hypothermic perfusion and active oxygenation designed to preserve donor kidneys and extend preservation time.
Organ perfusion cassette with integrated oxygenation and hermetic sealing
Disposable or single-use cassette designed to house organ(s) during machine perfusion with direct oxygenation, full organ immersion, and hermetic lid to reduce contamination risk; supports one or two kidneys.
Pulsatile perfusion preservation solution
Formulated perfusion fluid optimized for use with machine perfusion systems to support organ metabolism and reduce ischemic injury during hypothermic pulsatile perfusion.
Cold storage preservation solutions (kidney, liver, pancreas, heart)
Preservation fluids for static cold storage of donor organs including formulations intended for kidney, liver, pancreas and heart preservation.
Services
Secure cloud application that mirrors device UI to enable remote monitoring of perfusion parameters and coordination among clinical teams.
Manufacturer-provided repair and maintenance services for perfusion systems and consumables to restore or maintain device functionality.
Publishing and curating clinical studies, reviews, and meta-analyses related to organ preservation and machine perfusion to inform clinical adoption and product development.
Provision and distribution of perfusion platforms, organ cassettes, and preservation solutions for clinical use.
Secure cloud application that mirrors device UI to enable remote monitoring of perfusion parameters and coordination among clinical teams.
Manufacturer-provided repair and maintenance services for perfusion systems and consumables to restore or maintain device functionality.
Publishing and curating clinical studies, reviews, and meta-analyses related to organ preservation and machine perfusion to inform clinical adoption and product development.
Provision and distribution of perfusion platforms, organ cassettes, and preservation solutions for clinical use.
Expertise Areas
- Kidney preservation and transplant support
- Organ perfusion system engineering
- Preservation solution formulation
- Clinical evidence generation and literature synthesis
Key Technologies
- Hypothermic oxygenated machine perfusion (HOPE/HMPO2)
- Hypothermic machine perfusion (HMP)
- Normothermic machine perfusion (NMP)
- Pulsatile perfusion pump technology
News & Updates
Join Waters Medical Systems at the 2025 World Transplant Congress in San Francisco, August 2-5, booth 830, to discover the future of organ preservation.
Attend the AOPO 2025 in Denver, CO, June 22–24, 2025, to connect with organ, tissue, and eye procurement professionals.
A meta-analysis indicating HMPO2 may lower adverse events in kidney transplantation, especially in DCD cases.
The DCX cassette received FDA 510(k) clearance, advancing hypothermic kidney perfusion technology.
Milestone achievement enabling advanced organ preservation and expanding the donor pool.
Join Waters Medical Systems at the 2025 World Transplant Congress in San Francisco, August 2-5, booth 830, to discover the future of organ preservation.
Attend the AOPO 2025 in Denver, CO, June 22–24, 2025, to connect with organ, tissue, and eye procurement professionals.
A meta-analysis indicating HMPO2 may lower adverse events in kidney transplantation, especially in DCD cases.
The DCX cassette received FDA 510(k) clearance, advancing hypothermic kidney perfusion technology.
Milestone achievement enabling advanced organ preservation and expanding the donor pool.